EUVIMEDEUVIMED entdecken
Crossref

Multi-therapeutic strategy targeting Akt-mTOR and FoxO1 pathway to counteract skeletal muscle atrophy consecutive to hypoxia

Samir Bensaid iD, Claudine Fabre iD, Amir Yahya Rajaei, Charlotte Claeyssen, Frédéric N Daussin iD, Caroline Cieniewski-Bernard iD

American Journal of Physiology-Cell Physiology · 2025

DOI: 10.1152/ajpcell.00851.2024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2025. Verfasst von Samir Bensaid und 5 weiteren Autor:innen. Beteiligte Einrichtung: Université de Lille, L'Université d'Artois, Université du Littoral Côte d'Opale, ULR 7369-URePSSS-Unité de Recherche Pluridisciplinaire Sport Santé S…. Hauptthemen laut MEDLINE: Signal Transduction, Muscle, Skeletal, Muscular Diseases, Forkhead Box Protein O1. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Centre hospitalier régional universitaire de Lille (CHU).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our research demonstrates that combining electrical stimulation, BCAA supplementation, and oxygenation effectively counteracts hypoxia-induced muscle atrophy. Unlike isolated treatments, this multi-therapy approach significantly improves myotube morphology and regulates key protein homeostasis pathways, with mTOR activation protein and reduced myostatin expression. These findings highlight the enhanced therapeutic potential of combining physical activity, nutritional support, and oxygen therapy to prevent muscle atrophy in the detrimental reduction of oxygen supply.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionMuscle, SkeletalMuscular DiseasesForkhead Box Protein O1Cell HypoxiaAnimalsMiceCell LineProto-Oncogene Proteins c-aktAtrophyTOR Serine-Threonine Kinases

Stichwörter der Autor:innen

hypoxiaprotein homeostasissignaling pathwaysskeletal muscle

Substanzen

Proto-Oncogene Proteins c-aktmTOR protein, mouseTOR Serine-Threonine KinasesFoxo1 protein, mouseForkhead Box Protein O1

Autor:innen und Institutionen

  • Université de Lille, L'Université d'Artois, Université du Littoral Côte d'Opale, ULR 7369-URePSSS-Unité de Recherche Pluridisciplinaire Sport Santé Société, Lille, France.
  • CHU Lille, Université de Lille, Lille, France.
  • CERITD, French Center for Studies and Research on the Intensification of Diabetes Treatment, Evry, France.

ORCID-Profile: Samir Bensaid, Claudine Fabre, Frédéric N Daussin, Caroline Cieniewski-Bernard

Förderung

  • Centre hospitalier régional universitaire de Lille (CHU)

Zitieren

APA

Bensaid, S., Fabre, C., Yahya Rajaei, A., Claeyssen, C., Daussin, F. N., & Cieniewski-Bernard, C. (2025). Multi-therapeutic strategy targeting Akt-mTOR and FoxO1 pathway to counteract skeletal muscle atrophy consecutive to hypoxia. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00851.2024

Vancouver

Bensaid S, Fabre C, Yahya Rajaei A, Claeyssen C, Daussin FN, Cieniewski-Bernard C. Multi-therapeutic strategy targeting Akt-mTOR and FoxO1 pathway to counteract skeletal muscle atrophy consecutive to hypoxia. American Journal of Physiology-Cell Physiology. 2025. doi:10.1152/ajpcell.00851.2024

BibTeX
@article{Bensaid2025,
  author = {Bensaid, Samir and Fabre, Claudine and Yahya Rajaei, Amir and Claeyssen, Charlotte and Daussin, Frédéric N and Cieniewski-Bernard, Caroline},
  title = {Multi-therapeutic strategy targeting Akt-mTOR and FoxO1 pathway to counteract skeletal muscle atrophy consecutive to hypoxia},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2025},
  doi = {10.1152/ajpcell.00851.2024}
}
Kostenlos starten →